Photogrammetric Scan System for Body Composition Analysis
NCT ID: NCT05864820
Last Updated: 2024-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
75 participants
OBSERVATIONAL
2023-04-18
2024-06-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18 and 85
* Caucasian race
* Cognitively intact
* Acceptance and signing of informed consent
* Height between 120 and 200 cm (included)
Exclusion Criteria
* Implants resulting from cosmetic surgery
* Articular prostheses and/or means of synthesis
* Current oncological or metabolic pathologies
* Photosensitivity
* Epilepsy
* Claustrophobia
* Subjects unable to independently maintain an upright position
* Wearers of pacemakers
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matteo Briguglio
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto Ortopedico Galeazzi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Istituto Ortopedico Galeazzi
Milan, Milan, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L3052
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
AVATARGET (PI: M Briguglio)
Identifier Type: -
Identifier Source: org_study_id